New Drug Effective in Lung Cancers Caused by Genetic Error
NYU Langone research finds a new drug that can reduce the size of lung cancer tumors in people with a specific, disease-causing genetic change.
NYU Langone Health in the News— February 6, 2024
At NYU Langone, our experts are frequently featured in various media outlets to share their skills and knowledge. See the stories from February 6, 2024.
NYU Langone Health in the News—July 16, 2024
At NYU Langone, our experts are frequently featured in various media outlets to share their skills and knowledge. See the stories from July 16, 2024.
Immunology & Inflammation Mentoring Faculty | NYU Langone Health
NYU Grossman School of Medicine’s Immunology and Inflammation mentoring faculty reflect a variety of backgrounds and interests.
Gastrointestinal Cancer Disease Management Group Research | NYU Langone Health
At Perlmutter Cancer Center, our Gastrointestinal Cancer Disease Management Group research advances the clinical and basic science of GI cancers.
Predicting Patient Responses for Arthritic Conditions
NYU Langone’s Dr. Jose U. Scher and Dr. Rebecca Haberman are studying rheumatoid arthritis drug responses and psoriatic arthritis progression.
emergency-medicine-ultrasound-fellows.pdf
Ronald O. Perelman Department of Emergency Medicine
NYU Langone Health in the News— Tuesday, June 10, 2025
At NYU Langone, our experts are frequently featured in various media outlets to share their skills and knowledge. See the stories from June 10, 2025.
EPA1b Screening Ultrasound Supervision Tool
... ❏ Identify imaging artifacts and methods for correction ❏ Demonstrate the correct use of the BI-RADS lexicon ...
Developmental Genetics | NYU Langone Health
NYU Grossman School of Medicine’s Developmental Genetics PhD program focuses on genetic approaches to understanding developmental mechanisms.